The global contrast-enhanced ultrasound market is poised for remarkable growth, projected to achieve a market valuation of USD 9,214.3 million by 2033, as per research from Future Market Insights. This represents a significant leap from USD 5,243.3 million in 2023 and USD 2,700 million in 2022, with a robust CAGR of 5.8% anticipated between 2023 and 2033.
Revolutionizing Diagnostics:
The surge in demand for lung ultrasonography procedures is a key driver behind this growth, reflecting a broader shift toward advanced, non-invasive diagnostic technologies. Contrast-enhanced ultrasound (CEUS) has emerged as a pivotal tool, offering enhanced imaging precision across a wide range of medical applications.
Commenting on the trend, Future Market Insights stated:
“This remarkable growth underscores the increasing acceptance of contrast-enhanced ultrasound in the medical community. Its non-invasive nature and advanced imaging capabilities make it a game-changer in diagnostics.”
Market Insights and Highlights:
- Historical Growth: From 2017 to 2022, the global CEUS market grew at a CAGR of 4.7%, starting from a valuation of USD 2,146.0 million in 2017.
- Regional Leaders:
- North America dominates with a 36.0% market share, led by the United States, which holds 52.4% of the region’s market.
- Europe accounts for 28.0%, with Germany (7.0% share) and the UK (CAGR of 5.1%) being prominent contributors.
- Emerging markets like China (CAGR of 7.7%) and India (CAGR of 6.9%) are fueling growth in the Asia-Pacific region.
- Application Focus:
- Echocardiography leads the application segment, commanding 60.13% of the market share.
- Hospitals are the dominant end-users, accounting for 39% of revenue.
Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!
Competitive Landscape:
Prominent players driving innovation in the market include:
- Trivitron Healthcare
- Bracco Diagnostic Inc.
- GE Healthcare
- Siemens Healthcare GmbH
- B.K. Medical Holding Company, Inc.
Recent Developments:
- Acusphere, Inc., in June 2023, signed a definitive agreement with Cephalon, Inc., securing $20 million for developing its proprietary Hydrophobic Drug Delivery System (HDDS™)
- In April 2023, Bracco Imaging S.p.A. collaborated with SonoThera, Inc. to leverage microbubble technology for ultrasound-guided gene therapy solutions.
Key Segments Profiled in the Contrast-Enhanced Ultrasound Industry Survey:
Type:
- Non-Targeted
- Targeted
Application:
- Hepatic
- Echocardiography
- Cerebrovascular
- Thyroid & Parathyroid
- Gallbladder & Biliary Tree
- Renal
- Prostate
- Pancreatic
- Vascular
- Lymphatic
- Trauma
- Others
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube